Managing HIV. Part 2: Phases of disease. 2.4 HIV and advanced immune deficiency
Marriott, D.; McMurchie, M.
Medical Journal of Australia 164(2): 111-112
1996
ISSN/ISBN: 0025-729X PMID: 8569561 Document Number: 458689
Advanced immune deficiency is defined as a CD4 cell count below 200/microL. This phase is marked by considerable medical intervention requiring close coordination between general practitioner and specialist, with the goal of minimising the patient's time in hospital. The patient must be assisted with the psychological adjustments that lead to death with dignity. Managing HIV in all its manifestations will make a great difference to the quality of both life and death.
Document emailed within 1 workday
Related Documents
Kelleher, A.D.; Orth, D. 1996: Managing HIV. Part 2: Phases of disease. 2.2 Early HIV-induced immune deficiency Medical Journal of Australia 164(2): 107-108Ffrench, R.; Stewart, G.J.; Penny, R.; Levy, J.A. 1996: Managing HIV. Part 3. Mechanisms of disease. 3.2 how HIV produces immune deficiency Medical Journal of Australia 164(3): 166-171
McCluskey, P.J.; Hall, A.J.; Lightman, S. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.11 HIV and eye disease Medical Journal of Australia 164(8): 484-486
Wong, D.; Shumack, S. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.1 HIV and skin disease Medical Journal of Australia 164(6): 352-356
Frankum, B.S.; Savdie, E. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.10 HIV and renal disease Medical Journal of Australia 164(8): 483
Carr, A.; Garsia, R. 1996: Managing HIV. Part 3: Mechanisms of disease. 3.5 how HIV leads to hypersensitivity reactions Medical Journal of Australia 164(4): 227-229
Quertermous, J.; Bernardi, J.Michael.; Malone, J.; Callen, J.P. 2011: Resident rounds. Part III. Erosive and desquamative syphilis associated with mucositis in the setting of acquired immune deficiency syndrome Journal of drugs in dermatology: JDD 10(11): 1335-1336
Sievert, W.; Shaw, D.R.; Edwards, P. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.3 HIV, gastrointestinal and hepatobiliary disease Medical Journal of Australia 164(6): 360-365
Stewart, G.J.; Irvine, S.S.; Scott, M.; Kelleher, A.D.; Marriott, D.J.; McKnight, I.; Pethebridge, A.M.; Wodak, A.; Ziegler, J. 1996: Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV Medical Journal of Australia 164(2): 99-104
Zolla Pazner, S.; El Sadr, W.; William, D.; Stahl, R.; Marmor, M. 1985: The use of beta 2 microglobulin in the diagnosis of acquired immune deficiency syndrome suspected acquired immune deficiency syndrome and preclinical acquired immune deficiency syndrome Selikoff, I J , A S Teirstein And S Z Hirschman (Ed ) Annals Of The New York Academy Of Sciences, Vol 437 Acquired Immune Deficiency Syndrome; Meeting, New York, N Y , Usa, Nov 14-17, 1983 Xiv+622p The New York Academy Of Sciences; New York, N Y , Usa Illus 526-529, 1984
Jose, J.M.; Idiculla, J.M.; Ravindran, G.D. 2010: An autoimmune disease in an immune deficiency disorder National Medical Journal of India 23(4): 252
Weyna, E.; Braun, J.; Dabrowski, W.; Strzelecka, G. 1978: Immune resistance in advanced periodontal disease treated with rovamycin Czasopismo Stomatologiczne 31(10): 965-968
Boyko, W.J.; Schechter, M.T.; Craib, K.J.P.; Constance, P.; Nitz, R.; Fay, S.; Mcleod, A.; O'shaughnessy, M. 1986: The vancouver lymphadenopathy acquired immune deficiency syndrome study 5. antecedent behavioral clinical and laboratory findings in patients with acquired immune deficiency syndrome and human immunodeficiency virus seropositive controls Canadian Medical Association Journal 135(8): 881-887
Landay, A.L.; Bettendorf, D.; Chan, E.; Spritzler, J.; Schmitz, J.L.; Bucy, R.P.; Gonzalez, C.J.; Schnizlein-Bick, C.T.; Evans, T.; Squires, K.E.; Phair, J.P. 2002: Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease Aids Research and Human Retroviruses 18(2): 95-102
Weiden, P.L.; Blaese, R.M. 1971: Hemolytic anemia in agammaglobulinemic chickens: a model of "autoimmune" disease in immune deficiency Journal of Immunology 107(4): 1004-1013
Yu, S.S.; Dorff, T.B.; Ballas, L.K.; Sadeghi, S.; Skinner, E.C.; Quinn, D.I. 2017: Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease Clinical Advances in Hematology and Oncology: H&o 15(6): 466-477
Smith, H.R.; Chused, T.M.; Steinberg, A.D. 1983: The effect of the X-linked immune deficiency gene (xid) upon the y chromosome-related disease of BXSB mice Journal of Immunology 131(3): 1257-1262
Wolff, K. 1986: Neopterin in homosexuals acquired immune deficiency syndrome related complex and acquired immune deficiency syndrome patients a parameter for the activity of the lymphadenopathy associated virus human t cell leukemia virus iii infection Acta Medica Austriacaec. Issue: 41-42
Wolff, K. 1986: Neopterin in homosexuals acquired immune deficiency syndrome related complex and acquired immune deficiency syndrome patients a parameter for the activity of the lymphadenopathy associated virus human t cell leukemia virus iii infection Acta Medica Austriacaec. Issue: 41-42
Anon 1985: Instruction sheet no 43 acquired immune deficiency syndrome acquired immune deficiency syndrome in lymphadenopathy associated virus human t cell lymphotropic virus type iii infections recommendations for doctors Hygiene: 523-527